These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37311134)

  • 1. Impact of pre-operative weight loss on non-alcoholic fatty liver disease histopathology and insulin resistance in individuals undergoing bariatric surgery: a propensity matched cross-sectional comparison.
    Maldonado FHR; Mega PF; Germano CW; Dias LLC; Callejas GH; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
    Sao Paulo Med J; 2024; 142(1):e2022663. PubMed ID: 37311134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvesicular Steatosis in Individuals with Obesity: a Histological Marker of Non-alcoholic Fatty Liver Disease Severity.
    Germano CW; Mega PF; Mattosinho TJAP; Dias LLC; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
    Obes Surg; 2023 Mar; 33(3):813-820. PubMed ID: 36694089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Helicobacter pylori infection associated with non-alcoholic fatty liver disease in individuals undergoing bariatric surgery? Cross-sectional study.
    Valadares EC; Gestic MA; Utrini MP; Chaim FDM; Chaim EA; Cazzo E
    Sao Paulo Med J; 2023; 141(5):e2022517. PubMed ID: 37042863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score.
    Yeo SC; Ong WM; Cheng KSA; Tan CH
    Obes Surg; 2019 Apr; 29(4):1295-1300. PubMed ID: 30635812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Scores Assessing Histological Activity and Estimated Long-Term Risk Analysis of Hepatic Decompensation of Non-Alcoholic Fatty Liver Disease in Individuals Undergoing Bariatric Surgery.
    Hatto M; Ivano VK; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
    Obes Surg; 2023 May; 33(5):1580-1586. PubMed ID: 37004688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation Between Anthropometric Measurements and Non-alcoholic Fatty Liver Disease in Individuals With Obesity Undergoing Bariatric Surgery: Cross-Sectional Study.
    Reis SS; Callejas GH; Marques RA; Gestic MA; Utrini MP; Chaim FDM; Ramos AC; Chaim EA; Cazzo E
    Obes Surg; 2021 Aug; 31(8):3675-3685. PubMed ID: 33982243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic Fatty Liver Disease in Morbidly Obese Individuals Undergoing Bariatric Surgery: Prevalence and Effect of the Pre-Bariatric Very Low Calorie Diet.
    Schwenger KJP; Fischer SE; Jackson TD; Okrainec A; Allard JP
    Obes Surg; 2018 Apr; 28(4):1109-1116. PubMed ID: 29098545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SHOULD ROUTINE LIVER BIOPSY BE CONSIDERED IN BARIATRIC SURGICAL PRACTICE? AN ANALYSIS OF THE LIMITATIONS OF NON-INVASIVE NAFLD MARKERS.
    Concon MM; Gestic MA; Utrini MP; Chaim FDM; Chaim EA; Cazzo E
    Arq Gastroenterol; 2022; 59(1):110-116. PubMed ID: 35442320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Histopathological and Biochemical Aspects of NAFLD With the Severity of Liver Fibrosis in Individuals With Obesity: Cross-sectional Study.
    Carneiro CRG; Ayres ABS; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
    Obes Surg; 2024 May; 34(5):1569-1574. PubMed ID: 38502518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a preoperative low-calorie diet on liver histology in patients with fatty liver disease undergoing bariatric surgery.
    Wolf RM; Oshima K; Canner JK; Steele KE
    Surg Obes Relat Dis; 2019 Oct; 15(10):1766-1772. PubMed ID: 31558407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive role of parathyroid hormone for non-alcoholic fatty liver disease based on invasive and non-invasive findings in candidates of bariatric surgery.
    Jamialahmadi T; Nematy M; Jangjoo A; Goshayeshi L; Abdalla MA; Akhlaghi S; Sathyapalan T; Sahebkar A
    Eat Weight Disord; 2022 Mar; 27(2):693-700. PubMed ID: 33999371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bariatric Surgery in Nonalcoholic Fatty Liver Disease (NAFLD): Impact Assessment Using Paired Liver Biopsy and Fibroscan.
    Agarwal L; Aggarwal S; Shalimar ; Yadav R; Dattagupta S; Garg H; Agarwal S
    Obes Surg; 2021 Feb; 31(2):617-626. PubMed ID: 33052552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology.
    Bower G; Toma T; Harling L; Jiao LR; Efthimiou E; Darzi A; Athanasiou T; Ashrafian H
    Obes Surg; 2015 Dec; 25(12):2280-9. PubMed ID: 25917981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Factors Associated with Hepatic Iron Overload in Obese Individuals Undergoing Bariatric Surgery: a Cross-Sectional Study.
    Jesus RN; Callejas GH; Concon MM; Braga JGR; Marques RA; Chaim FDM; Gestic MA; Utrini MP; Ramos AC; Chaim EA; Cazzo E
    Obes Surg; 2020 Dec; 30(12):4967-4973. PubMed ID: 32979184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of bariatric surgery on non-alcoholic fatty liver disease.
    Major P; Pędziwiatr M; Rubinkiewicz M; Stanek M; Głuszewska A; Pisarska M; Małczak P; Budzyński A; Budzyński P
    Pol Przegl Chir; 2017 Apr; 89(2):1-4. PubMed ID: 28537562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
    Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
    Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of bariatric surgeries on nonalcoholic fatty liver disease.
    Aldoheyan T; Hassanain M; Al-Mulhim A; Al-Sabhan A; Al-Amro S; Bamehriz F; Al-Khalidi H
    Surg Endosc; 2017 Mar; 31(3):1142-1147. PubMed ID: 27405478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic and liver-related outcomes of bariatric surgery in adult patients with insulin-treated type 2 diabetes and nonalcoholic fatty liver disease at high risk of liver fibrosis.
    Alkharaiji M; Anyanwagu U; Crabtree T; Idris I
    Surg Obes Relat Dis; 2021 Apr; 17(4):792-798. PubMed ID: 33676874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.